Michael D. Pak

Array ( [id] => 5700674 [patent_doc_number] => 20060217359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Therapeutic procedures' [patent_app_type] => utility [patent_app_number] => 11/369206 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 38101 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217359.pdf [firstpage_image] =>[orig_patent_app_number] => 11369206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631509 [patent_doc_number] => 20060147978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Methods and compositions for screening for altered cellular phenotypes' [patent_app_type] => utility [patent_app_number] => 11/361631 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 46591 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147978.pdf [firstpage_image] =>[orig_patent_app_number] => 11361631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112941 [patent_doc_number] => 20070196856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Methods of determining activity of ryanodine receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/362319 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6673 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196856.pdf [firstpage_image] =>[orig_patent_app_number] => 11362319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596223 [patent_doc_number] => 20060160140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Human nuclear receptor protein nNR7-1' [patent_app_type] => utility [patent_app_number] => 11/355324 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14294 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160140.pdf [firstpage_image] =>[orig_patent_app_number] => 11355324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753968 [patent_doc_number] => 20060223117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Novel splice variants of human epithelial sodium channel genes expressed in human taste tissue and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/345403 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16161 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223117.pdf [firstpage_image] =>[orig_patent_app_number] => 11345403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572331 [patent_doc_number] => 07829527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Emergence of a R-type Ca2+ channel (Cav 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage' [patent_app_type] => utility [patent_app_number] => 11/346614 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 32 [patent_no_of_words] => 18944 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829527.pdf [firstpage_image] =>[orig_patent_app_number] => 11346614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102625 [patent_doc_number] => 07728107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Canine 5-hydroxytryptamine 2A and 2B receptor' [patent_app_type] => utility [patent_app_number] => 11/795278 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16025 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728107.pdf [firstpage_image] =>[orig_patent_app_number] => 11795278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894358 [patent_doc_number] => 20080103457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Method and System for Treating Heart Failure' [patent_app_type] => utility [patent_app_number] => 11/813574 [patent_app_country] => US [patent_app_date] => 2006-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6926 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103457.pdf [firstpage_image] =>[orig_patent_app_number] => 11813574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602242 [patent_doc_number] => 20060292587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Polynucleotides encoding insect voltage-gated chloride channel and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/330550 [patent_app_country] => US [patent_app_date] => 2006-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16197 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292587.pdf [firstpage_image] =>[orig_patent_app_number] => 11330550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792657 [patent_doc_number] => 20080293631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Treatment for Autoimmune and Inflammatory Conditions' [patent_app_type] => utility [patent_app_number] => 11/813506 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8863 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293631.pdf [firstpage_image] =>[orig_patent_app_number] => 11813506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5860189 [patent_doc_number] => 20060229435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Lymphocyte homing receptors' [patent_app_type] => utility [patent_app_number] => 11/327164 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15587 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229435.pdf [firstpage_image] =>[orig_patent_app_number] => 11327164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574220 [patent_doc_number] => 07829672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Modulation of sodium channels in dorsal root ganglia' [patent_app_type] => utility [patent_app_number] => 11/324768 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 19091 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829672.pdf [firstpage_image] =>[orig_patent_app_number] => 11324768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865510 [patent_doc_number] => 20060099640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'SLO2 and SLO4, novel potassium channel proteins from human brain' [patent_app_type] => utility [patent_app_number] => 11/325764 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30325 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099640.pdf [firstpage_image] =>[orig_patent_app_number] => 11325764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 423825 [patent_doc_number] => RE039849 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-09-18 [patent_title] => 'Methods for identifying modulators of CCX CKR activity' [patent_app_type] => reissue [patent_app_number] => 11/324118 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 23647 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039849.pdf [firstpage_image] =>[orig_patent_app_number] => 11324118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53500 [patent_doc_number] => 07767409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Method for detection of substance bound to nuclear receptor' [patent_app_type] => utility [patent_app_number] => 11/887477 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 6946 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767409.pdf [firstpage_image] =>[orig_patent_app_number] => 11887477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742810 [patent_doc_number] => 20060088535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Method for enhancing long-term memory in a subject and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/301602 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16071 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088535.pdf [firstpage_image] =>[orig_patent_app_number] => 11301602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11886914 [patent_doc_number] => 09757461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'GnRH analogue formulations' [patent_app_type] => utility [patent_app_number] => 11/795250 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 19673 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11795250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385649 [patent_doc_number] => 20090226894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'METHOD FOR MEASURING RESISTANCE OR SENSITIVITY TO DOCETAXEL' [patent_app_type] => utility [patent_app_number] => 11/721103 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14413 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226894.pdf [firstpage_image] =>[orig_patent_app_number] => 11721103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843180 [patent_doc_number] => 20060121508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Alternatively spliced isoforms of purinergic receptor P2X, ligand-gated ion channel, subunits 3 and 4 (P2RX3, P2RX4)' [patent_app_type] => utility [patent_app_number] => 11/284978 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23541 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121508.pdf [firstpage_image] =>[orig_patent_app_number] => 11284978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648938 [patent_doc_number] => 20060134670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Enabling tools to identify ligands for hormone nuclear receptors' [patent_app_type] => utility [patent_app_number] => 11/283329 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21359 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134670.pdf [firstpage_image] =>[orig_patent_app_number] => 11283329 [rel_patent_id] =>[rel_patent_doc_number] =>)